Protocol update and baseline characteristics for the TRIal to slow the Progression of Diabetes (TRIPOD) randomized controlled trial.

ABSTRACT:

Background

Type 2 diabetes (T2D), a major risk factor for cardiovascular disease and other adverse health conditions, is on the rise in Singapore. TRIPOD is a randomized controlled trial aimed to determine whether complementing usual care with an evidence-based diabetes management package (DMP) -comprising access to an evidence-based app, health coaching, pedometer, glucometer and weighing scale, with or without a financial rewards scheme (M-POWER rewards), can improve mean HbA_1c levels at months 6 and 12.

Methods

The protocol was published in Trials, accessible via https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-019-3749-x ¹. This manuscript updates the protocol with changes to the study design due to challenges with recruitment and pre

SUBMITTER: Bairavi J 

PROVIDER: S-EPMC10647071 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature